- Home
- AVIR vs RDW Comparison
AVIR vs RDW Comparison
Compare AVIR & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- RDW
- Stock Information
- Founded
- AVIR 2012
- RDW 2020
- Country
- AVIR United States
- RDW United States
- Employees
- AVIR N/A
- RDW N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- RDW Military/Government/Technical
- Sector
- AVIR Health Care
- RDW Industrials
- Exchange
- AVIR Nasdaq
- RDW Nasdaq
- Market Cap
- AVIR 284.5M
- RDW 449.1M
- IPO Year
- AVIR 2020
- RDW N/A
- Fundamental
- Price
- AVIR $3.60
- RDW $5.76
- Analyst Decision
- AVIR Hold
- RDW Strong Buy
- Analyst Count
- AVIR 1
- RDW 4
- Target Price
- AVIR $6.88
- RDW $8.06
- AVG Volume (30 Days)
- AVIR 198.5K
- RDW 347.2K
- Earning Date
- AVIR 08-07-2024
- RDW 11-04-2024
- Dividend Yield
- AVIR N/A
- RDW N/A
- EPS Growth
- AVIR N/A
- RDW N/A
- EPS
- AVIR N/A
- RDW N/A
- Revenue
- AVIR N/A
- RDW $292,000,000.00
- Revenue This Year
- AVIR N/A
- RDW $27.68
- Revenue Next Year
- AVIR N/A
- RDW $15.54
- P/E Ratio
- AVIR N/A
- RDW N/A
- Revenue Growth
- AVIR N/A
- RDW 39.94
- 52 Week Low
- AVIR $2.77
- RDW $2.35
- 52 Week High
- AVIR $4.60
- RDW $8.23
- Technical
- Relative Strength Index (RSI)
- AVIR 45.68
- RDW 40.75
- Support Level
- AVIR $3.57
- RDW $6.46
- Resistance Level
- AVIR $3.89
- RDW $7.06
- Average True Range (ATR)
- AVIR 0.14
- RDW 0.39
- MACD
- AVIR -0.03
- RDW -0.06
- Stochastic Oscillator
- AVIR 17.02
- RDW 6.32
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About RDW Redwire Corporation
Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.